Klingenstein Fields & CO LP Gsk PLC Transaction History

Klingenstein Fields & CO LP

$2.48 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$42.05 - $47.77 $172,615 - $196,095	-4,105 Reduced 2.49%	160,713 $7 Million
Q1 2022 Apr 27, 2022	SELL	$40.23 - $47.74 $22,327 - $26,495	-555 Reduced 0.34%	164,818 $7.18 Million
Q4 2021 Jan 31, 2022	SELL	$38.88 - $45.31 $85,497 - $99,636	-2,199 Reduced 1.31%	165,373 $7.29 Million
Q3 2021 Oct 26, 2021	SELL	$38.79 - $43.16 $134,795 - $149,981	-3,475 Reduced 2.03%	167,572 $6.4 Million
Q2 2021 Jul 26, 2021	SELL	$36.52 - $41.46 $349,496 - $396,772	-9,570 Reduced 5.3%	171,047 $6.81 Million
Q1 2021 Apr 29, 2021	SELL	$34.27 - $40.01 $663,158 - $774,233	-19,351 Reduced 9.68%	180,617 $6.45 Million
Q4 2020 Feb 02, 2021	SELL	$34.07 - $39.94 $57,714 - $67,658	-1,694 Reduced 0.84%	199,968 $7.36 Million
Q3 2020 Oct 30, 2020	SELL	$38.11 - $42.99 $657,511 - $741,706	-17,253 Reduced 7.88%	201,662 $7.59 Million
Q2 2020 Aug 03, 2020	SELL	$37.87 - $43.58 $127,659 - $146,908	-3,371 Reduced 1.52%	218,915 $8.93 Million
Q1 2020 May 07, 2020	SELL	$32.47 - $48.83 $153,096 - $230,233	-4,715 Reduced 2.08%	222,286 $8.42 Million
Q4 2019 Feb 04, 2020	SELL	$42.0 - $48.25 $121,674 - $139,780	-2,897 Reduced 1.26%	227,001 $10.7 Million
Q3 2019 Nov 01, 2019	SELL	$40.46 - $43.52 $14,686 - $15,797	-363 Reduced 0.16%	229,898 $9.81 Million
Q2 2019 Aug 12, 2019	SELL	$39.4 - $42.7 $92,629 - $100,387	-2,351 Reduced 1.01%	230,261 $9.22 Million
Q1 2019 Apr 29, 2019	SELL	$38.57 - $42.69 $8.86 Million - $9.8 Million	-229,621 Reduced 49.68%	232,612 $9.72 Million
Q4 2018 Jan 22, 2019	SELL	$37.8 - $42.69 $136,080 - $153,684	-3,600 Reduced 0.77%	462,233 $17.7 Million
Q3 2018 Nov 01, 2018	BUY	$39.75 - $42.69 $17,768 - $19,082	447 Added 0.1%	465,833 $18.7 Million
Q2 2018 Jul 26, 2018	SELL	$39.61 - $42.76 $95,460 - $103,051	-2,410 Reduced 0.52%	465,386 $18.8 Million
Q1 2018 May 01, 2018	SELL	$36.18 - $40.15 $34,190 - $37,941	-945 Reduced 0.2%	467,796 $18.3 Million
Q4 2017 Jan 30, 2018	SELL	$35.34 - $41.9 $332,196 - $393,860	-9,400 Reduced 1.97%	468,741 $16.6 Million
Q3 2017 Nov 01, 2017	BUY	$39.44 - $41.55 $18.9 Million - $19.9 Million	478,141	478,141 $19.4 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Klingenstein Fields & CO LP with notifications on news.

Account